SCHEMBL7799486

SCHEMBL7799486

CCOC(=O)C(CC(=O)c1cccc(F)c1)(NC(C)=O)C(=O)OCC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.54
ALDH1A1 P00352 2/20 0.51
RECQL P46063 1/20 0.51
KDM4E B2RXH2 5/20 0.47
PKM P14618 2/20 0.47
THRB P10828 1/20 0.46
LMNA P02545 4/20 0.45
HTT P42858 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPSR1 Q6W5P4 4/20 0.44
ATM Q13315 2/20 0.44
MAPT P10636 6/20 0.44
HPGD P15428 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPC1 O15118 3/20 0.43
TSHR P16473 3/20 0.43
KCNH2 Q12809 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7791489 0.86 ALDH1A1 (0.49) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL7800778 0.85 ALDH1A1 (0.51) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL5036126 0.84 ALDH1A1 (0.66) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL7801944 0.84 ALDH1A1 (0.50) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL7801948 0.84 LMNA (0.47) POLBALDH1A1KDM4ELMNAHTT
SCHEMBL7799501 0.79 ALDH1A1 (0.49) ALDH1A1RECQLKDM4EPKMTHRB
SCHEMBL8397322 0.79 ALDH1A1 (0.46) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL7800755 0.78 ALDH1A1 (0.45) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL5402060 0.78 ALDH1A1 (0.60) POLBALDH1A1RECQLKDM4EPKM
SCHEMBL7797578 0.78 ALDH1A1 (0.50) POLBALDH1A1RECQLKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT POLB 1971/4885ALDH1A1 615/4885RECQL 4560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.